Chong Kun Dang enters 'fifth' P1 study of diabetes combo drug < Pharma < 기사본문 - KBR
Diabetes Tips, News & Articles
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, ...
Note: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, ...
Chong Kun Dang recently received regulatory approval to conduct its fifth phase 1 clinical trial of CKD-393, a new drug candidate for diabetes, ...
Read moreNote: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online